A risk balancing act - Tourism competition using health leverage in the COVID-19 era.


Journal

The International journal of risk & safety in medicine
ISSN: 1878-6847
Titre abrégé: Int J Risk Saf Med
Pays: Netherlands
ID NLM: 9100907

Informations de publication

Date de publication:
2020
Historique:
pubmed: 1 7 2020
medline: 4 9 2020
entrez: 30 6 2020
Statut: ppublish

Résumé

The world is currently in the throes of the COVID-19 pandemic which has halted the tourism sector and created an unprecedented global economic crisis. This paper will outline economics pertaining to COVID-19 lockdown, recovery and the inevitable competition that will occur between countries for tourists who will be scarcer and therefore more valuable. Countries are competing with a variety of incentives in order to lure visitors. However, persistent first waves that extend into July will put off tourists, further reducing tourism revenues and accelerate job losses and bankruptcies in affected countries. The example of Sweden's response to COVID-19 in this regard will be described. Countries that have COVID-19 relatively under control but experience second waves will also manifest negative tourism effects. Governments and public health must act in unison so as to exit lockdown as speedily and as safely as feasible, with COVID-19 rises that are as low and brief as possible in order to better compete in the tourism sector with other countries. Websites are already online comparing not only safety for travellers vis-à-vis COVID-19 but also the incentives offered by different countries in their attempts to woo tourists in this difficult market.

Identifiants

pubmed: 32597822
pii: JRS200042
doi: 10.3233/JRS-200042
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-130

Auteurs

Victor Grech (V)

Paediatric Department, University of Malta, Mater Dei Hospital, Malta.

Peter Grech (P)

Accounting and Economics Student, Malta.

Stephanie Fabri (S)

Faculty of Economics, Management & Accountancy, University of Malta, Malta.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH